FUNDING INNOVATIVE TREATMENTS THROUGH COMPENSATION Several new treatments are being developed for people who have asbestos-related diseases. Through interim payments or a fast conclusion to settlement for asbestos exposure, compensation can be recovered directly to access these innovative treatments that may not be available on the NHS or are in the experimental stage and are only available privately or in other countries. Clinical Trials and Research: Ongoing clinical trials and research explore the efficacy of various immunotherapy drugs and combinations in treating mesothelioma. These trials aim to uncover new insights and develop more effective treatment regimens, offering hope for improved survival and quality of life for mesothelioma patients. Potential and Hope: While a series of treatments, including immunotherapy, are not a cure for mesothelioma, they have shown significant promise in managing the disease, slowing its progression, and improving the quality of life for patients.
The advancements in treatments, including immunotherapy, cancer drugs such as Avastin linked with chemotherapy and stereotactic radiotherapy, are a beacon of hope for those battling mesothelioma, opening new avenues for treating and managing this aggressive disease. Clinical Trials: Patients may be able to participate in clinical trials, which are research studies involving people. These trials aim to find new ways to prevent, detect, or treat disease and improve quality of life.
Funding Innovative Treatments Through Compensation
8
Made with FlippingBook interactive PDF creator